|
 |
|
|||||||
|
|||||||||
© 2002 by the American Diabetes Association, Inc.
Fetal Insulin-Like Growth Factor-2 Production Is Impaired in the GK Rat Model of Type 2 Diabetes
1 Laboratory of Physiopathology of Nutrition, Université Paris, Paris, France
2 Instituto de Bioquimica, Facultad de Farmacia, Ciudad Universitaria, Madrid, Spain
At late fetal age (21.5 days postcoitum [dpc]), GK rats present a severely reduced ß-cell mass compared with Wistar rats. This anomaly largely antedates the onset of hyperglycemia in GK rats. Thus, the ß-cell mass deficit could represent the primary defect leading to type 2 diabetes in the adult. The aim of this work was to investigate, in GK fetuses at the end of fetal age (21.5 dpc), whether impaired availability of growth factors such as insulin, growth hormone, and IGFs and their IGF binding proteins (IGFBPs) could be instrumental in this anomaly. Although it confirms that GK fetuses are hypoinsulinemic despite enhanced plasma glucose level due to maternal hyperglycemia, the present study shows for the first time that IGF-2 expression in the liver and pancreas and IGF-2 serum levels are decreased in GK fetuses. Serum level as well as liver and pancreatic mRNA expression of IGFBP-2 were found to be normal in GK fetuses, whereas serum level and liver mRNA expression of IGFBP-1 were increased. Finally, we found that the maximal ß-cell mitogenic response to IGFs in vitro is kept intact, therefore suggesting that the direct biological action of IGFs on fetal GK ß-cells is not grossly impaired. In conclusion, in GK fetuses at 21.5 dpc, the defective IGF-2 production appears to be an early landmark in the pathological sequence leading to retardation of ß-cell growth in the fetal GK rat.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  L.-S. Fetita, E. Sobngwi, P. Serradas, F. Calvo, and J.-F. Gautier Consequences of Fetal Exposure to Maternal Diabetes in Offspring J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3718 - 3724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Villuendas, J. I Botella-Carretero, A. Lopez-Bermejo, C. Gubern, W. Ricart, J. M. Fernandez-Real, J. L S. Millan, and H. F Escobar-Morreale The ACAA-insertion/deletion polymorphism at the 3' UTR of the IGF-II receptor gene is associated with type 2 diabetes and surrogate markers of insulin resistance. Eur. J. Endocrinol., August 1, 2006; 155(2): 331 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A Martin, P. Serradas, S. Ramos, E. Fernandez, L. Goya, M. N. Gangnerau, M. Lacorne, A. M. Pascual-Leone, F. Escriva, B. Portha, et al. Protein-Caloric Food Restriction Affects Insulin-Like Growth Factor System in Fetal Wistar Rat Endocrinology, March 1, 2005; 146(3): 1364 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Duarte, M. S. Santos, R. Seica, and C. R. Oliveira Oxidative Stress Affects Synaptosomal {gamma}-Aminobutyric Acid and Glutamate Transport in Diabetic Rats: The Role of Insulin Diabetes, August 1, 2004; 53(8): 2110 - 2116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Butler, J. Jang, T. Gurlo, M. D. Carty, W. C. Soeller, and P. C. Butler Diabetes Due to a Progressive Defect in {beta}-Cell Mass in Rats Transgenic for Human Islet Amyloid Polypeptide (HIP Rat): A New Model for Type 2 Diabetes Diabetes, June 1, 2004; 53(6): 1509 - 1516. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |